Press Releases
Brinks Gilson & Lione Shareholder Marc Richards Co-Chairs Plenary Session at 2017 AIPPI World Congress in Sydney and Nominated to Be Re-elected Vice-Chair of AIPPI-US National Group
October 17, 2017

CHICAGO—On October 14, 2017, Marc V. Richards, a shareholder and patent attorney at intellectual property law firm Brinks Gilson & Lione, was panel co-chair for the plenary session “Study on Inventor Remuneration” at the 2017 AIPPI World Congress in Sydney, Australia.

The plenary session considered the issue of compensating inventors, and specifically discussed a study by AIPPI’s standing committee on patents concerning global harmonization on the standards for compensation paid to inventors for inventions made during their employment, which is of great concern to multi-national corporations. Participants in the session debated a draft position statement, in order that the committee may develop a resolution on inventor remuneration for adoption at AIPPI’s Cancun Congress in 2018.

Brinks' Richards is currently Vice-Chair of the AIPPI-US national group and is nominated to be re-elected to Vice-Chair at the AIPPI-US annual meeting taking place on October 20, 2017 during the AIPLA annual meeting in Washington DC.  He has been active for many years in the leadership of AIPPI-US national group, which is a division of the American Intellectual Property Law Association (AIPLA), and also active with the international AIPPI organization. Before becoming Vice-Chair, he completed a one-year term as treasurer and a two-year term as a member of the steering committee for the AIPPI-US group. In 2016, Richards served as international chair of the study committee on the Question of Security Interests Over IP at the AIPPI Congress in Milan; in 2014, Richards was U.S. group chair of the Q241 working committee on IP Licensing and Insolvency at the AIPPI Congress in Toronto; in 2011, Richards served as international chair of the Q217 working committee for AIPPI's forum and executive committee meeting in Hyderabad; in 2010, he was U.S. group chair of the Q213 working committee at the AIPPI Congress in Paris.

With almost 25 years of experience in intellectual property law, Richards focuses his practice at Brinks on patent prosecution and litigation, adversarial proceedings at the U.S. Patent and Trademark Office, and global patent portfolio management for clients with diverse technologies. He also counsels clients on patent infringement and invalidity investigations, licensing, and trade secret matters. Richards is the co-chair of Brinks' chemicals, energy, and agriculture practice and is the former co-chair of its post-grant patent practice.

Celebrating its 120th anniversary this year, AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle, or the International Association for the Protection of Intellectual Property) is a global organization that strives to advance the development, expansion, and improvement of international and regional treaties and agreements, as well as national laws, related to intellectual property. AIPPI is comprised of businesses, executives, lawyers, educators, patent and trademark agents, intellectual property owners, and others interested in the worldwide protection of patents, designs, trademarks, trade names, know how, goodwill, copyright, and other intellectual property rights, and in the elimination of unfair trade practices. The organization’s annual World Congress offers attendees a comprehensive educational program and extensive networking opportunities.

More information is at

Brinks Gilson & Lione

Celebrating its centennial year in 2017, Brinks Gilson & Lione is one of the largest intellectual property law firms in the US, and helps clients around the world to protect and enforce their intellectual property rights. Brinks Gilson & Lione’s more than 140 lawyers, patent agents and scientific advisors assist clients in all aspects of patent, trademark, unfair competition, trade secret, and copyright law. Brinks attorneys provide informed counsel with respect to innovations in a range of complex and valuable technologies, including pharmaceuticals, chemicals, bioengineering, industrial manufacturing, electronics and software, and medical devices. More information is at